Accessibility Menu
 
Aravive logo

Aravive

(NASDAQ) ARAV

Current PriceN/A
Market CapN/A
Since IPO (2014)-100%
5 Year-99%
1 Year-98%
1 Month-69%

Aravive Financials at a Glance

Market Cap

N/A

Revenue (TTM)

$7.00M

Net Income (TTM)

$81.15M

EPS (TTM)

N/A

P/E Ratio

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

ARAV News

No articles available.

ARAV: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Aravive

Industry

Biotechnology

Employees

23

CEO

Gail Frances McIntyre, PhD

Headquarters

Houston, TX 77098, US

ARAV Financials

Key Financial Metrics (TTM)

Gross Margin

-6%

Operating Margin

-8%

Net Income Margin

-9%

Return on Equity

-3%

Return on Capital

-2%

Return on Assets

-1%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/A

Shares Outstanding

N/A

Volume

N/A

Short Interest

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

$57.80M

Operating Income

$70.84M

EBITDA

$70.84M

Operating Cash Flow

$65.08M

Capital Expenditure

$11.00K

Free Cash Flow

$65.09M

Cash & ST Invst.

$53.69M

Total Debt

$6.27M

Aravive Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2023YOY CHG

Revenue

$2.76M

-44.4%

Gross Profit

$5.97M

+56.4%

Gross Margin

-2.17%

N/A

Market Cap

N/A

N/A

Market Cap/Employee

N/A

N/A

Employees

23

N/A

Net Income

$21.23M

+245.1%

EBITDA

$37.92M

-147.9%

Quarterly Fundamentals

Name
Q3 2023YOY CHG

Net Cash

$6.11M

-73.7%

Accounts Receivable

$0.00

-100.0%

Inventory

$0.00

N/A

Long Term Debt

$306.00K

-87.4%

Short Term Debt

$2.12M

-4.5%

Return on Assets

-1.30%

N/A

Return on Invested Capital

-1.70%

N/A

Free Cash Flow

$9.81M

+48.2%

Operating Cash Flow

$9.81M

+48.2%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
AFMDAffimed N.V.
$0.18+0.00%
IDRAIdera Pharmaceuticals, Inc.
$0.42-23.04%
RVLPRVL Pharmaceuticals plc
$0.03-32.05%
PTNPalatin Technologies, Inc.
$19.99-3.20%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$38.78-0.06%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$8.28+0.05%
QQQInvesco QQQ Trust
$562.58-0.02%
ARTLArtelo Biosciences
$10.54+2.30%

Questions About ARAV

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.